eagle-i University of Hawaii at ManoaUniversity of Hawaii at Manoa
See it in Search
This page is a preview of the following resource. Continue onto eagle-i search using the button on the right to see the full record.

Phase II prospective trial correlating progression free survival with CYP2D6 activity in patients with metastatic breast cancer treated with single agent tamoxifen

eagle-i ID


Resource Type

  1. Clinical trial


  1. ClinicalTrials.gov url
  2. Intervention
    Tamoxifen citrate
  3. Resource Description
    Hormone therapy using tamoxifen citrate may fight cancer by blocking the use of estrogen by tumor cells. This phase II trial is studying how well tamoxifen citrate works in patients with metastatic or recurrent breast cancer.
  4. Contact
    Berenberg, Jeffrey
  5. PI
    Berenberg, Jeffrey
  6. Topic
    breast cancer
  7. Study Population
    Men and women at least 18 years old with estrogen receptor-positive and/or progesterone receptor-positive disease and measurable or non-measurable disease.
  8. Website(s)
  9. Funded by
    Cancer Trials Support Unit
  10. Phase
    Phase 2 clinical trial
  11. Performed by
    Clinical Protocol & Data Management Shared Resource
Provenance Metadata About This Resource Record
Copyright © 2016 by the President and Fellows of Harvard College
The eagle-i Consortium is supported by NIH Grant #5U24RR029825-02 / Copyright 2016